GP681 not checked

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

FollowEvery change as it happens, and a Monday email
Stage
in China
Next date
Phase 3 trial completes
Trials
2 active
10 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Influenza, Human, Influenza
Main trialPhase 3
“This study will evaluate the efficacy, safety, and population pharmacokinetics of a single, oral dose of GP681 compared with placebo in patients aged 12 and older With Influenza at High Risk of Influenza Complications.”In the company’s words, NCT06573008 on ClinicalTrials.gov
Other names
Reference treatment · Test Treatment

Other drugs for Influenza, Human

All 30 drugs for Influenza, Human

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials10

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 30 Dec 2025 Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications
Phase 3Recruiting 30 Jul 2027 Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza
Phase 3Completed 25 Apr 2023 To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection
Phase 2Completed 18 Dec 2021 A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza
Phase 1Completed 15 Dec 2020 Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects
Phase 1Completed 22 Nov 2021 A Phase I Mass Balance Study of [14C]GP681 in Healthy Chinese Male Volunteers
Phase 1Completed 3 Aug 2023 GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers
Phase 1Completed 11 Sep 2023 A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers
Phase 1Completed 18 Jan 2025 Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension
Phase 1Completed 16 Feb 2025 Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow GP681

Following is part of Solo: you see every change to GP681 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in